Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleb Slobodin

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Microvascular Research|July 14, 2022
Nailfold video capillaroscopy as a useful diagnostic tool in systemic vasculitisShiri Keret, Jan Mazzawi, Gleb Slobodin, et al.
International Journal of Molecular Sciences|July 13, 2024
Tofacitinib Regulates Endostatin via Effects on CD147 and Cathepsin SDevy Zisman, Hala Sabtan, Maya M Rahat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosisDoron Rimar, Itzhak Rosner, Yuval Nov, et al.
Rheumatology (Oxford, England)|May 21, 2025
Leg edema in systemic sclerosis: uncovering fasciitis and myositis as key underlying causesShiri Keret, Merav Lidar, Aniela Shouval, et al.
Clinical Rheumatology|April 12, 2019
Infliximab for the treatment of refractory polyarteritis nodosaShira Ginsberg, Itzhak Rosner, Gleb Slobodin, et al.
Frontiers in Immunology|February 6, 2024
Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20SMaya M Rahat, Hala Sabtan, Elina Simanovich, et al.
Rheumatology (Oxford, England)|May 14, 2024
Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approachShiri Keret, Boris Chutko, Idit Dobrecky-Mery, et al.
Annals of the Rheumatic Diseases|August 26, 2016
Tofacitinib for polyarteritis nodosa: a tailored therapyDoron Rimar, Ayelet Alpert, Elina Starosvetsky, et al.
Rheumatology (Oxford, England)|December 9, 2025
Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort studyShiri Keret, Shlomit Yaari, Aniela Shouval, et al.
The Israel Medical Association Journal : IMAJ|February 12, 2020
Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in IsraelDoron Rimar, Yonatan Butbul Aviel, Aharon Gefen, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Microvascular Research|July 14, 2022
Nailfold video capillaroscopy as a useful diagnostic tool in systemic vasculitisShiri Keret, Jan Mazzawi, Gleb Slobodin, et al.
International Journal of Molecular Sciences|July 13, 2024
Tofacitinib Regulates Endostatin via Effects on CD147 and Cathepsin SDevy Zisman, Hala Sabtan, Maya M Rahat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosisDoron Rimar, Itzhak Rosner, Yuval Nov, et al.
Rheumatology (Oxford, England)|May 21, 2025
Leg edema in systemic sclerosis: uncovering fasciitis and myositis as key underlying causesShiri Keret, Merav Lidar, Aniela Shouval, et al.
Clinical Rheumatology|April 12, 2019
Infliximab for the treatment of refractory polyarteritis nodosaShira Ginsberg, Itzhak Rosner, Gleb Slobodin, et al.
Frontiers in Immunology|February 6, 2024
Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20SMaya M Rahat, Hala Sabtan, Elina Simanovich, et al.
Rheumatology (Oxford, England)|May 14, 2024
Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approachShiri Keret, Boris Chutko, Idit Dobrecky-Mery, et al.
Annals of the Rheumatic Diseases|August 26, 2016
Tofacitinib for polyarteritis nodosa: a tailored therapyDoron Rimar, Ayelet Alpert, Elina Starosvetsky, et al.
Rheumatology (Oxford, England)|December 9, 2025
Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort studyShiri Keret, Shlomit Yaari, Aniela Shouval, et al.
The Israel Medical Association Journal : IMAJ|February 12, 2020
Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in IsraelDoron Rimar, Yonatan Butbul Aviel, Aharon Gefen, et al.
Pageof 15